Design of clinical trials to assess diabetes treatment: Minimum duration of continuous glucose monitoring data to estimate time‐in‐ranges with the desired precision-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design of clinical trials to assess diabetes treatment: Minimum duration of continuous glucose monitoring data to estimate time‐in‐ranges with the desired precision

Published:2021-07-21 Issue:11 Volume:23 Page:2446-2454
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Camerlingo Nunzio¹^ORCID,Vettoretti Martina¹,Sparacino Giovanni¹,Facchinetti Andrea¹,Mader Julia K.²^ORCID,Choudhary Pratik³⁴,Del Favero Simone¹^ORCID,

Affiliation:

1. Department of Information Engineering University of Padova Padova Italy

2. Division of Endocrinology and Diabetology Medical University of Graz Graz Austria

3. Department of Diabetes School of Life Course Sciences, King's College London London UK

4. Department of Diabetes, Leicester Diabetes Centre University of Leicester Leicester UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14483

Reference26 articles.

1. International Consensus on Use of Continuous Glucose Monitoring

2. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

3. Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

4. Standardizing Clinically Meaningful Outcome Measures Beyond HbA1cfor Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange

5. Time in range: a new parameter to evaluate blood glucose control in patients with diabetes

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy;Diabetes Technology & Therapeutics;2024-01-01

2. Predicting Phase 1 Lymphoma Clinical Trial Durations Using Machine Learning: An In-Depth Analysis and Broad Application Insights;Clinics and Practice;2023-12-29

3. Bayesian denoising algorithm dealing with colored, non-stationary noise in continuous glucose monitoring timeseries;Frontiers in Bioengineering and Biotechnology;2023-11-22

4. Research progress in the application of time in range: more than a percentage;Chinese Medical Journal;2023-03-05

5. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement;The Lancet Diabetes & Endocrinology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3